AstraZeneca approaches Gilead about potential merger
AstraZeneca, valued at $140 billion, is the UK.’s biggest drugmaker by market capitalization. Gilead is the creator of a drug that’s received US approval for use with coronavirus patients.from Markets-Economic Times https://ift.tt/2Yds86Q
Post a Comment